Germline mutations in BAP1 impair its function in DNA double-strand break repair.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Cancer Research

• Publication date

  2014-08-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-13-3109PMID 24894717
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Poly(ADP-ribosyl)ation links the chromatin remodeler SMARCA5/SNF2H to RNF168-dependent DNA damage signaling

  2013cited by this paper
• Regulation of DNA damage responses by ubiquitin and SUMO.

  2013cited by this paper
• 53BP1 is a reader of the DNA damage-induced H2A Lys15 ubiquitin mark

  2013cited by this paper
• BAP1 is phosphorylated at serine 592 in S‐phase following DNA damage

  2013cited by this paper
• The role of the histone H2A ubiquitinase Sce in Polycomb repression

  2012cited by this paper
• BAP1 loss defines a new class of renal cell carcinoma

  2012cited by this paper
• RNF168 ubiquitinates K13-15 on H2A/H2AX to drive DNA damage signaling.

  2012cited by this paper
• Germline mutations in BAP1 predispose to melanocytic tumors

  2011cited by this paper
• The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma

  2011influential reference
• BRCA1 tumor suppression occurs via heterochromatin mediated silencing

  2011cited by this paper
• Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers

  2011cited by this paper
• BMI1 Is Recruited to DNA Breaks and Contributes to DNA Damage-Induced H2A Ubiquitination and Repair

  2011cited by this paper
• Germline BAP1 mutations and tumor susceptibility

  2011cited by this paper
• Correct End Use during End Joining of Multiple Chromosomal Double Strand Breaks Is Influenced by Repair Protein RAD50, DNA-dependent Protein Kinase DNA-PKcs, and Transcription Context*

  2011cited by this paper
• Germline BAP1 mutations predispose to malignant mesothelioma

  2011cited by this paper
• Monoubiquitination of H2AX Protein Regulates DNA Damage Response Signaling

  2011cited by this paper
• Identification of breast tumor mutations in BRCA1 that abolish its function in homologous DNA recombination.

  2010cited by this paper
• ATM-dependent chromatin changes silence transcription in cis to DNA double-strand breaks.

  2010influential reference
• A viral E3 ligase targets RNF8 and RNF168 to control histone ubiquitination and DNA damage responses

  2010cited by this paper
• The Ubiquitin Carboxyl Hydrolase BAP1 Forms a Ternary Complex with YY1 and HCF-1 and Is a Critical Regulator of Gene Expression

  2010cited by this paper
• Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB

  2010influential reference
• BMI1-mediated histone ubiquitylation promotes DNA double-strand break repair

  2010influential reference
• Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas

  2010cited by this paper
• Focus on histone variant H2AX: To be or not to be

  2010cited by this paper
• The ubiquitous role of ubiquitin in the DNA damage response

  2010cited by this paper
• The Lys63-specific Deubiquitinating Enzyme BRCC36 Is Regulated by Two Scaffold Proteins Localizing in Different Subcellular Compartments*

  2010influential reference
• Genetic sequence variations of BRCA1-interacting genes AURKA, BAP1, BARD1 and DHX9 in French Canadian Families with high risk of breast cancer

  2009cited by this paper
• BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity.

  2009cited by this paper
• The ubiquitin landscape at DNA double-strand breaks

  2009cited by this paper
• The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling cascade at sites of DNA damage.

  2009cited by this paper
• Defining the human deubiquitinating enzyme interaction landscape.

  2009cited by this paper
• RNF168 binds and amplifies ubiquitin conjugates on damaged chromosomes to allow accumulation of repair proteins.

  2009cited by this paper
• The Rap80-BRCC36 de-ubiquitinating enzyme complex antagonizes RNF8-Ubc13-dependent ubiquitination events at DNA double strand breaks

  2009cited by this paper
• The Deubiquitinating Enzyme BAP1 Regulates Cell Growth via Interaction with HCF-1*

  2009cited by this paper
• Association of C-Terminal Ubiquitin Hydrolase BRCA1-Associated Protein 1 with Cell Cycle Regulator Host Cell Factor 1

  2009cited by this paper
• Regulatory ubiquitylation in response to DNA double-strand breaks.

  2009cited by this paper
• Alternative-NHEJ Is a Mechanistically Distinct Pathway of Mammalian Chromosome Break Repair

  2008cited by this paper
• Proteome-wide identification of poly(ADP-ribose) binding proteins and poly(ADP-ribose)-associated protein complexes

  2008cited by this paper
• BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization.

  2008cited by this paper
• RNF8 transduces the DNA-damage signal via histone ubiquitylation and checkpoint protein assembly.

  2007cited by this paper
• ATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage

  2007cited by this paper
• Deubiquitination of FANCD2 Is Required for DNA Crosslink Repair

  2007cited by this paper
• Orchestration of the DNA-Damage Response by the RNF8 Ubiquitin Ligase

  2007cited by this paper
• Human USP3 is a chromatin modifier required for S phase progression and genome stability.

  2007cited by this paper
• RNF8 ubiquitylates histones at DNA double-strand breaks and promotes assembly of repair proteins.

  2007cited by this paper
• A role for the deubiquitinating enzyme USP28 in control of the DNA-damage response.

  2006cited by this paper
• The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway.

  2005cited by this paper
• Polycomb group proteins Ring1A/B link ubiquitylation of histone H2A to heritable gene silencing and X inactivation.

  2004cited by this paper
• Role of histone H2A ubiquitination in Polycomb silencing

  2004cited by this paper
• The E2 Ubiquitin Conjugase Rad6 Is Required for the ArgR/Mcm1 Repression of ARG1 Transcription

  2002cited by this paper
• Cancer-predisposing mutations within the RING domain of BRCA1: Loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity

  2001cited by this paper
• Defining biochemical functions for the BRCA1 tumor suppressor protein: analysis of the BRCA1 binding protein BAP1.

  1999cited by this paper
• BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression

  1998cited by this paper
• The ubiquitin-conjugating enzyme Rad6 (Ubc2) is required for silencing in Saccharomyces cerevisiae

  1997cited by this paper
• Exclusive production of bistranded DNA damage by calicheamicin.

  1993cited by this paper

• BAP1 loss impairs Non-Homologous End Joining DNA repair promoting genomic instability

  2026cites this paper
• BRCA1-Associated Protein 1 (BAP1) in Human Cancer and its Emerging Role as a Novel Potential Therapeutic Target

  2026cites this paper
• Oncogenesis in cholangiocarcinoma.

  2026cites this paper
• BAP1-loss in mesothelioma: molecular mechanisms and clinical opportunities

  2026cites this paper
• Broadening the Clinical and Molecular Spectrum of BAP1 Tumor Predisposition Syndrome: Findings from the First Reported Turkish Cohort

  2025cites this paper
• Characterization of BRCA1‐Associated Protein‐1 (BAP1) Aggregation Properties Induced by Cancer‐Associated Mutations

  2025cites this paper
• Pleural mesothelioma

  2025cites this paper
• Regulation of BAP1 activity by novel cancer-associated glutamate residues through ubiquitin binding and PARylation.

  2025cites this paper
• Deciphering the mechanisms of PARP inhibitor resistance in prostate cancer: Implications for precision medicine.

  2025cites this paper
• The PRC2.1 subcomplex opposes G1 progression through regulation of CCND1 and CCND2

  2025cites this paper
• Current Therapies and Potential Strategies for Uveal Melanoma.

  2025cites this paper
• Application of circulating tumor DNA liquid biopsy in nasopharyngeal carcinoma: A case report and review of literature

  2025cites this paper
• Molecular Mechanisms of Tumor Progression and Novel Therapeutic and Diagnostic Strategies in Mesothelioma

  2025cites this paper
• UFMylation maintains tumor suppressor pVHL stability by activating the deubiquitinase BAP1

  2025cites this paper
• Challenges and Strategies to Enhance Drug Efficacy of the Approved Drugs for Chemoresistant Triple-Negative Breast Cancer: A Narrative Review

  2025cites this paper
• Malignant mesothelioma with a novel BAP1 germline frameshift mutation treated with dual immune checkpoint inhibitors: A case report.

  2025cites this paper
• An overview of BAP1 biological functions and current therapeutics.

  2025cites this paper
• Loss of BAP1 defines a unique subtype of TP53-mutated de novo AML and confers sensitivity to BCL-xL inhibitors.

  2025cites this paper
• Advances in the relationship of immune checkpoint inhibitors and DNA damage repair.

  2025cites this paper
• PARP1 cooperates with ASXL1 to stimulate BAP1 deubiquitinase activity through its DNA-binding domain.

  2025cites this paper
• Phase II Trial of the PARP Inhibitor, Niraparib, in BAP1 and Other DNA Damage Response Pathway-Deficient Neoplasms

  2024cites this paper
• Genomic characterization and detection of potential therapeutic targets for peritoneal mesothelioma in current practice

  2024cites this paper
• The BAP1 nuclear deubiquitinase is involved in the nonhomologous end-joining pathway of double-strand DNA repair through interaction with DNA-PK

  2024cites this paper
• DoUBLing up: ubiquitin and ubiquitin-like proteases in genome stability

  2024cites this paper
• Research on molecular characteristics of ADME-related genes in kidney renal clear cell carcinoma

  2024cites this paper
• Combination of EZH2 and ATM inhibition in BAP1-deficient mesothelioma

  2024cites this paper
• The PRC2.1 Subcomplex Opposes G1 Progression through Regulation of CCND1 and CCND2

  2024cites this paper
• The genetic susceptibility in the development of malignant pleural mesothelioma: somatic and germline variants, clinicopathological features and implication in practical medical/surgical care: a narrative review

  2024cites this paper
• BAP1-mediated MAFF deubiquitylation regulates tumor growth and is associated with adverse outcomes in colorectal cancer.

  2024cites this paper
• Histone H2A variants play a key role at DNA double-strand breaks during repair pathway choice

  2024cites this paper
• BRCA1‐associated protein 1: Tumor predisposition syndrome and Kury‐Isidor syndrome, from genotype–phenotype correlation to clinical management

  2024cites this paper
• BAP1 Deficiency Inflames the Tumor Immune Microenvironment and Is a Candidate Biomarker for Immunotherapy Response in Malignant Pleural Mesothelioma

  2024cites this paper
• Structural basis of histone H2A lysine 119 deubiquitination by Polycomb repressive deubiquitinase BAP1/ASXL1

  2023cites this paper
• Pleural mesothelioma: a snapshot of emerging drug targets and opportunities for non-surgical therapeutic advancement

  2023cites this paper
• Altered cytoplasmic and nuclear ADP‐ribosylation levels analyzed with an improved ADP‐ribose binder are a prognostic factor in renal cell carcinoma

  2023influential citation
• Mutational signature of extracranial meningioma metastases and their respective primary tumors

  2023cites this paper
• BAP1 as a guardian of genome stability: implications in human cancer

  2023cites this paper
• Targeting BAP1 with small compound inhibitor for colon cancer treatment

  2023cites this paper
• Deubiquitylating Enzymes in Cancer and Immunity

  2023cites this paper
• Expanded detection and impact of BAP1 alterations in cancer

  2023cites this paper
• Structural basis of histone H2A lysine 119 deubiquitination by Polycomb Repressive Deubiquitinase BAP1/ASXL1

  2023cites this paper
• Complete clinical remission of malignant peritoneal mesothelioma with systemic pemetrexed and bevacizumab in a patient with a BAP1 mutation

  2023cites this paper
• Pharmacological inhibition of BAP1 recruits HERC2 to competitively dissociate BRCA1–BARD1, suppresses DNA repair and sensitizes CRC to radiotherapy

  2023cites this paper
• DNA repair and damage pathways in mesothelioma development and therapy

  2022cites this paper
• Advances in drug treatments for mesothelioma

  2022cites this paper
• Homologous Recombination Repair in Biliary Tract Cancers: A Prime Target for PARP Inhibition?

  2022cites this paper
• ATR represents a therapeutic vulnerability in clear cell renal cell carcinoma

  2022cites this paper
• DNA Damage Response Regulation by Histone Ubiquitination

  2022cites this paper
• Diagnostic and Therapeutic Challenges of Malignant Pleural Mesothelioma

  2022cites this paper
• BMI-1 regulates DNA end resection and homologous recombination repair.

  2022cites this paper
• Clinical Benefit of Niraparib to TKI/mTORi-Resistance Metastatic ccRCC With BAP1-Frame Shift Mutation: Case Report and Literature Review

  2022cites this paper
• An Update on Emerging Therapeutic Options for Malignant Pleural Mesothelioma

  2022cites this paper
• BAP1 in cancer: epigenetic stability and genome integrity

  2022cites this paper
• BAP1 maintains HIF-dependent interferon beta induction to suppress tumor growth in clear cell renal cell carcinoma.

  2022cites this paper
• BAP1 promotes the repair of UV-induced DNA damage via PARP1-mediated recruitment to damage sites and control of activity and stability.

  2022cites this paper
• Choroidal melanoma with synchronous Fuchs’ adenoma and novel ATRX mutation

  2022cites this paper
• Recent Advances and Challenges in Uveal Melanoma Immunotherapy

  2022cites this paper
• Mechanisms orchestrating the enzymatic activity and cellular functions of deubiquitinases

  2022cites this paper
• What's Current and What's New in Mesothelioma?

  2022cites this paper
• Mice lacking DCAF2 in placenta die at the gastrulation stage

  2022cites this paper
• PBRM1, SETD2 and BAP1 — the trinity of 3p in clear cell renal cell carcinoma

  2022cites this paper
• Somatic BAP1 Loss as a Predictive Biomarker of Overall Survival in Patients With Malignant Pleural Mesothelioma Treated With Chemotherapy.

  2022cites this paper
• Medical and surgical care of mesothelioma patients and their relatives carrying germline BAP1 mutations.

  2022cites this paper
• Rucaparib in patients with BAP1-deficient or BRCA1-deficient mesothelioma (MiST1): an open-label, single-arm, phase 2a clinical trial.

  2021cites this paper
• Integrated, Integral, and Exploratory Biomarkers in the Development of Poly(ADP-Ribose) Polymerase Inhibitors

  2021cites this paper
• Pre-Clinical Research Advancements Relating to Improving the Diagnosis and Treatment of Malignant Pleural Mesothelioma: A Review

  2021cites this paper
• A computational prognostic model of lncRNA signature for clear cell renal cell carcinoma with genome instability

  2021cites this paper
• Diagnostic utility of BAP1 for malignant pleural mesothelioma in pleural fluid specimens with atypical morphology

  2021cites this paper
• Precision Therapy for Mesothelioma: Feasibility and New Opportunities

  2021cites this paper
• Dysregulation of the Ubiquitin Proteasome System in Human Malignancies: A Window for Therapeutic Intervention

  2021cites this paper
• Genetic Predisposition to Mesothelioma: What Are the Biological Mechanisms and What Are the Clinical Characteristics of These Mesotheliomas?

  2021cites this paper
• Understanding and overcoming resistance to PARP inhibitors in cancer therapy

  2021cites this paper
• Roles and mechanisms of BAP1 deubiquitinase in tumor suppression

  2021cites this paper
• Proteomic analysis identifies novel binding partners of BAP1

  2021cites this paper
• Immunotherapy in uveal melanoma: novel strategies and opportunities for personalized treatment

  2021cites this paper
• Role of deubiquitinating enzymes in DNA double-strand break repair

  2021cites this paper
• Tumor Treating Fields (TTFields) downregulate the Fanconi Anemia-BRCA pathway and increase the efficacy of chemotherapy in malignant pleural mesothelioma preclinical models.

  2021cites this paper
• Emerging multifaceted roles of BAP1 complexes in biological processes

  2021cites this paper
• Diagnostic mesothelioma biomarkers in effusion cytology

  2021cites this paper
• Alterations in BAP1 Are Associated with Cisplatin Resistance through Inhibition of Apoptosis in Malignant Pleural Mesothelioma

  2021cites this paper
• Regulation of Histone Ubiquitination in Response to DNA Double Strand Breaks

  2020cites this paper
• BAP1: Not just a BRCA1-associated protein.

  2020cites this paper
• The critical role of BAP1 mutation in the prognosis and treatment selection of kidney renal clear cell carcinoma

  2020cites this paper
• Clear cell renal cell carcinoma ontogeny and mechanisms of lethality

  2020cites this paper
• Mutations in renal cell carcinoma.

  2020cites this paper
• Polycomb group-mediated histone H2A monoubiquitination in epigenome regulation and nuclear processes

  2020cites this paper
• Cancer-Related Increases and Decreases in Calcium Signaling at the Endoplasmic Reticulum-Mitochondria Interface (MAMs).

  2020cites this paper
• Newly identified Gon4l/Udu-interacting proteins implicate novel functions

  2020cites this paper
• Biological Mechanisms and Clinical Significance of BAP1 Mutations in Human Cancer.

  2020cites this paper
• Emerging roles of microRNAs and their implications in uveal melanoma

  2020cites this paper
• BAP1 is a haploinsufficient tumor suppressor linking chronic pancreatitis to pancreatic cancer in mice

  2020cites this paper
• MOLECULAR CANCER THERAPEUTICS | CANCER BIOLOGYAND TRANSLATIONAL STUDIES Functional Genomic Screen inMesotheliomaReveals that Loss of Function of BRCA1-Associated Protein 1 Induces Chemoresistance to Ribonucleotide Reductase Inhibition

  2020cites this paper
• Meningiomas: Comprehensive Strategies for Management

  2020cites this paper
• BAP1 Tumor Predisposition Syndrome

  2020cites this paper
• Hereditary predisposition to uveal melanoma

  2020cites this paper
• Role of Deubiquitinases in Human Cancers: Potential Targeted Therapy

  2020cites this paper
• Perfecting DNA double-strand break repair on transcribed chromatin.

  2020cites this paper
• Emerging Meningioma Therapies I: Precision Medicine, Targeted Therapies, and Mutation-Specific Approaches

  2020cites this paper
• How asbestos and other fibers cause mesothelioma

  2020cites this paper
• BAP1: role in carcinogenesis and clinical implications

  2020influential citation